UroGen Pharma (URGN) Earnings
|
Expand Research on URGN
| Next EPS Date | 8/6/26 | EPS Growth Rate | +72.4% |
|---|---|---|---|
| Average EPS % Beat Rate | -8.6% | Revenue Growth Rate | +153.9% |
| Average % Move 1-Wk after EPS | +12.5% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/6/26  |
Q226 | N/A | -$0.29 | N/A | N/A | $61.45M | N/A | N/A | N/A | ||
| 5/6/26 | Q126 | -$0.47 | -$0.50 | +$0.03 | $50.96M | $44.46M | N/A |  | | Details | |
| 3/2/26 | Q425 | -$0.54 | -$0.48 | -$0.06 | $37.84M | $41.45M | N/A | | | Details | |
| 11/6/25 | Q325 | -$0.69 | -$0.68 | -$0.01 | $27.48M | $33.19M | N/A | | | Details | |
| 8/7/25 | Q225 | -$1.05 | -$0.83 | -$0.22 | $24.2M | $23.13M | N/A | | | Details | |
| 5/12/25 | Q125 | -$0.92 | -$0.79 | -$0.13 | $20.25M | $22.5M | N/A | | | Details | |
| 3/10/25 | Q424 | -$0.80 | -$0.77 | -$0.03 | $24.56M | $28.24M | N/A | | | Details | |
| 11/6/24 | Q324 | -$0.55 | -$0.82 | +$0.27 | $25.2M | $24.2M | = | | | Details |
